#USA #New York #HilleVax #Y-mAbs #Aris Water

Halper Sadeh LLC Investigates Shareholder Rights

On August 8, 2025, Halper Sadeh LLC, a law firm dedicated to the protection of investor rights, announced plans to investigate potential legal violations involving several publicly traded companies. These include Aris Water Solutions, Inc. (NYSE: ARIS), Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB), and HilleVax, Inc. (NASDAQ: HLVX).

Background on the Investigations

Halper Sadeh LLC is probing each company's recent transactions that may not align with the best interests of their shareholders. The focus is primarily on two upcoming transactions involving these companies:

1. Aris Water Solutions, Inc.
- Aris is examining the sale of Western Midstream Partners, LP, where shareholders have the choice between receiving either 0.625 common units of the partnership for every Aris share or a cash payment of $25.00 per share. Given the options available, the firm aims to protect shareholders who may feel disadvantaged by the sale process.

2. Y-mAbs Therapeutics, Inc.
- Y-mAbs recently announced a sale to SERB Pharmaceuticals at a price of $8.60 per share in cash. Concerns have surfaced surrounding this deal regarding whether the offered price adequately reflects the company’s value and future prospects, raising potential fiduciary duty breaches by the company's board.

3. HilleVax, Inc.
- HilleVax is poised to sell to XOMA Royalty Corporation. The transaction details indicate that HilleVax shareholders will receive $1.95 in cash per share, along with one non-transferable contingent value right that could entitle them to further payments contingent upon specific conditions. Halper Sadeh is scrutinizing whether adequate disclosures and terms have been provided to shareholders, ensuring they understand the full implications of this deal.

The Firm's Approach

Halper Sadeh LLC highlights its commitment to maximizing shareholder returns. During the investigations, the law firm may pursue various forms of relief, which may include securing increased financial consideration for shareholders, obtaining additional disclosures about the transactions, or even initiating legal actions. Importantly, the legal firm operates on a contingent fee basis, meaning shareholders will not incur out-of-pocket expenses. Instead, the firm recovers fees from settlements or awarded damages, alleviating financial pressure on affected shareholders.

How Shareholders Can Get Involved

Aris, Y-mAbs, and HilleVax shareholders are encouraged to reach out to Halper Sadeh for a no-cost consultation to understand their rights regarding these transactions. They can contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or via email at [email protected].

Conclusion

Halper Sadeh LLC represents investors globally, aiming to address instances of securities fraud and corporate misconduct. By thoroughly evaluating the rights and options available to shareholders of Aris, Y-mAbs, and HilleVax, the firm seeks to ensure fair treatment and recourse for those who feel their interests have not been adequately protected. As the investigations proceed, it will be crucial for shareholders to stay informed and engaged with developments in these companies.

In this landscape of corporate actions and market fluctuations, shareholder awareness and action are paramount. It is the hope of Halper Sadeh LLC that their initiative will lead to improved conditions for investors and corporate accountability across the board.